Safety and Efficacy of QAX576 in Patients With Progressive Idiopathic Pulmonary Fibrosis (IPF)

Mise à jour : Il y a 4 ans
Référence : EUCTR2010-020688-18

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

• To evaluate the safety and tolerability of multiple intravenous dosing of QAX576 in patients with IPF • To evaluate the effect of multiple intravenous dosing of QAX576 on lung function assessed by FVC at 1 year as compared to baseline


Critère d'inclusion

  • Patients with rapidly progressive idiopathic pulmonary fibrosis

Liens